Nicotine pouches are a cheap substitute for actually policing illicit tobacco

Cabinet has obtained approval in principle to allow sales of oral nicotine pouches, pitching them as a weapon against illicit tobacco. The theory is tidy: give smokers a legal, lower-risk alternative, they quit cigarettes, and demand for smuggled product dries up. The problem is that almost nothing in the public record shows the theory works.

There is a respectable pro-market case for bringing products out of the shadows and regulating them in proportion to risk. But a legal market is only better than a black one if it actually displaces it. On current evidence, ministers are legalising on hope.

The black market is expensive and growing

The fiscal stakes are real. The Cabinet paper records that Customs seized nearly 15 million illegal cigarettes and 8 tonnes of illicit loose tobacco at the border in 2025, and that forecast excise revenue fell by $230 million that year. Officials themselves caution the drop is unlikely to reflect lower smoking alone, which is a polite way of saying a chunk of it leaked to criminals.

For legitimate retailers, that leakage is direct competition from operators who pay no excise and ignore the rules. Any serious response should be judged on whether it closes that gap.

A product its maker won’t call a quitting aid

The paper argues pouches could help people stop smoking. Yet Philip Morris, which makes ZYN, has said its pouches are “not an alternative to quitting” and not designed as cessation aids. It is unusual for a government to make stronger health claims for a product than the company selling it.

The clinical evidence is meagre. In 2024, Otago researchers noted the strongest available trial involved just 45 participants, 18 of them given pouches, with an eight-week follow-up, over 25% lost to follow-up, and a design measuring cigarettes per day rather than quitting. In 2025, The Conversation reported that Ministry of Health officials had advised there was no evidence supporting pouches as cessation aids, and that a systematic review found no evidence they reduce smoking or vaping prevalence.

To justify the move, the Cabinet paper leans on vaping, citing 230,000 people quitting between 2018 and 2023. That is evidence about a different product. Borrowing it to sell pouches is analogy, not analysis.

Mentioned 40 times, proven zero

The Public Health Communication Centre’s 5 November briefing counts the word “illicit” 40 times in the Cabinet paper, which nonetheless “provides no evidence that easier access to alternative products will counter the illicit tobacco market.” The same briefing notes the Ministry had previously advised against legalisation over youth uptake risks, and that Cabinet first agreed to the idea in 2024. This has been on the shelf for two years without the supporting evidence turning up.

The PHCC is a public health outfit with a clear view, and business readers can discount for that. But the gap it identifies is one the government should be able to fill easily if the data existed. It hasn’t.

The pouches are already on the counter

Here is the awkward part for anyone pitching legalisation as a fix for unregulated retail. Pouches are illegal to sell now, yet among adults who smoke, reported current use jumped from 1% to 14% between 2025 and 2026. Of those users, 68% bought them from dairies, petrol stations, vape shops or tobacco stores, and 95% reported coupons, sales or promotions, which are already banned.

That is not a shadowy import channel. It is mainstream retail openly breaking existing law, with apparently little consequence. In 2025, Otago’s Professor Janet Hoek told RNZ the products were “highly addictive and particularly appealing to young people.”

If the state cannot enforce a sales ban, it is not obvious why it will enforce age limits, flavour rules or promotion restrictions once the product is legal. Legalisation without enforcement capacity simply hands a legal shield to the operators already ignoring the rules, while compliant retailers carry the paperwork.

The lever that actually works costs money

Academic analysis of New Zealand’s illicit market over more than a decade, published in BMJ Public Health, points to border scrutiny, enforcement and lower smoking prevalence as the effective levers, not new product categories. Enforcement is unglamorous, needs Customs and compliance staff, and does not come with a press release. It is also a core function of government, which fiscally conservative ministers should be the first to defend when $230 million in excise is walking out the door.

The Cabinet paper promises a “risk proportionate regulatory regime.” Fair enough, if it comes with funded enforcement and evidence targets. The test before legislation is introduced is simple: show the modelling linking pouch access to lower illicit tobacco demand, and show the enforcement budget that stops dairies selling to teenagers. Without both, this is not harm reduction or market reform. It is a shortcut, and the bill will land on retailers who play by the rules and taxpayers covering the revenue hole.

Sources

• Newsroom: The nicotine pouch fix is a false promise (2026-11-14)
• Ministry of Health: Cabinet Paper – Addressing the Illicit Market and Achieving our Smokefree Goal (2026-10-01)
• PHCC: Can oral tobacco and nicotine products help people to stop smoking? (2024-08-13)
• The Conversation: 8 reasons the government should not introduce oral nicotine pouches to NZ (2025-12-09)
• PHCC: Why the Government should rethink plans to legalise oral nicotine products (2026-11-05)
• PHCC: Rapid rise in oral nicotine pouch use highlights need for vigilance (2026-10-07)
• RNZ: What are nicotine pouches and should we be worried? (2025-12-11)